| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $84.28B | $84.04B | $82.01B |
| YoY Revenue Growth % | +0.3% | +2.5% | — |
| Gross Profit | $43.12B | $43.19B | — |
| Gross Margin % | 51.2% | 51.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $20.45B | $18.55B | $18.13B |
| Operating Margin % | 24.3% | 22.1% | 22.1% |
| Net Income (GAAP) | $15.97B | $14.88B | $14.65B |
| EBITDA (Normalized) | $23.47B | $21.20B | $21.09B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $17.82B | $19.85B | $16.85B |
| Capital Expenditures (CapEx) | $3.77B | $3.32B | $3.69B |
| Free Cash Flow (FCF) | $14.04B | $16.52B | $13.16B |
| FCF Margin % | 16.7% | 19.7% | 16.0% |
| Return on Invested Capital (ROIC %) | 24.9% | 23.2% | 11.6% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $25.58B | $25.26B | $47.90B |
| Total Stockholders' Equity | $53.32B | $51.44B | $98.26B |